FDA Panel Narrowly Backs Avacopan Approval FDA Panel Narrowly Backs Avacopan Approval

The FDA is mulling whether to approve avacopan for ANCA-associated vasculitis largely on the basis of a single trial about which the agency staff has concerns.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news